A common point of opposition to offering buprenorphine in correctional settings is the perceived risk of diversion, disciplinary issues, or safety concerns created by allowing access to buprenorphine.
Vital Strategies supported technical assistance to six county jails in Pennsylvania that had been funded by the Commonwealth to expand access to buprenorphine to incarcerated persons.
This snapshot looks at the reported incidence of diversion, assault, and conduct citations at the six jails in Pennsylvania that together provided buprenorphine to more than 1,000 individuals over an 18 month period through this state-funded grant program.
Recent Abstracts
Effects of Heat on Early Childhood Development
Blood Lead Surveillance of Children and Pregnant Women in Tamil Nadu, India
Sportswashing through Media: Coca-Cola’s Olympic Play – A Research Report
What’s in Our Food?
Mais Dados Mais Saúde
More Data, Better Health – Primary Health Care
Mais Dados Mais Saúde: Experiência De Discriminação Cotidiana Pela População Brasileira
More Data, Better Health – Experience of everyday Discrimination by the Brazilian population
Monitoramento de Estratégias pelo Fim da Violência contra Crianças e Adolescentes
Harm Reduction: The Neglected Pillar of US Drug Policy